# SMART-SF Radiofrequency Ablation Safety Study

Study · id `cardio:ct-nct02359890` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02359890](<https://clinicaltrials.gov/study/NCT02359890>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02359890

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

## Technical summary

Registry record NCT02359890. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03-01 (actual); primary completion 2015-09-01 (actual). Results posted on 2017-10-17.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 165 participants (enrolled count; ClinicalTrials.gov record NCT02359890, source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)
- Started: 2015-03-01 (actual) (ClinicalTrials.gov record NCT02359890, source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)
- Primary completion: 2015-09-01 (actual) (ClinicalTrials.gov record NCT02359890, source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)
- Completion: 2016-11-08 (actual) (ClinicalTrials.gov record NCT02359890, source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)
- Results first posted: 2017-10-17 (ClinicalTrials.gov record NCT02359890, source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02359890-2025-02-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: SMART-SF Radiofrequency Ablation Safety Study
- Condition: Atrial Fibrillation
- Intervention (Device): THERMOCOOL® SMARTTOUCH® (RF ablation treatment)
- Lead sponsor: Biosense Webster, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: e52153e5c688f45987be45a26d882cb8694a9f71cb5b5d2fb6234a10bb50e3d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
